Americans support letting the government negotiate drug prices above all the other major priorities in the infrastructure and social spending packages now before Congress, according to a new POLITICO-Harvard poll that suggests health care is at the top of most respondents’ minds.
But the drug pricing plan could be in peril as some centrist Democrats spar with Speaker Nancy Pelosi over the scope and details. Democratic leaders are now considering scaling back a House leadership-backed proposal or dropping it entirely from the $3.5 trillion social spending package.
The poll signals that despite President Joe Biden’s “Build Back Better” agenda and weekslong debates about the economic recovery, Americans are still most concerned about issues that impact them directly, said Robert Blendon, a professor of health policy and political analysis at the Harvard T.H. Chan School of Public Health who designed the poll. CONTINUED
Sarah Owermohle, Politico
The OPINION TODAY email newsletter is a concise daily rundown of significant new poll results and insightful analysis. It’s FREE. Sign up here: opiniontoday.substack